SEQ ID NO.1 of Patent CN113912739A

General Information


DCTPep ID  DCTPep06016

Peptide Name   SEQ ID NO.1 of Patent CN113912739A

Sequence  QRDMHSHRDFQPVLVALNSPLSGGMRDRG

Sequence Length  29

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

ACP Cancer targeted peptides α6β1 inhibitor



Activity Information


Cell Line Disease Activity Assay Testing Time Literature
PC-3 Prostate carcinoma 10% Survival=200 μg/ml MTT assay 24h Patent

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  α6β1

Affinity  Not available

Mechanism  Not available



Structure Information


PDB ID  Not available

Predicted Structure  Not available

(Please note that there is the predicted structure, predicted by AlphaFold)

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C137H222N48O42S2

Absent amino acids  CEIKTWY

Theoretical pI  9.46

Acidic residues  3

Basic residues  6

Polar residues  7

Molecular weight (Average)  3277.69

Molecular weight (Monoisotopic)  3275.62

Common amino acids  R

Net charge  3

Instability index (II)  51.37

Aliphatic index  63.79

Grand average of hydropathicity (GRAVY)  -0.828

Half Life 
  0.8 hours (mammalian reticulocytes, in vitro).
  10 min (yeast, in vivo).
  10 hours (Escherichia coli, in vivo).

Extinction coefficients 
  Should not be visible by UV spectrophotometry.

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID CN113912739A

Patent Title  Endostatin 33 peptide with anti-tumor activity and application thereof

Other Iinformation  Not available

Other Published ID  Not available




DCTPep is developed by Dr.Zheng's team.